drugset / Trial / NCT07386587

Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis

NCT07386587

Phase 3 Enrolling by invitation 60 enrolled University of Child Health Sciences and Children's Hospital, Lahore
RandomizedParallel-groupOpen-labelTreatment

Summary

This open labelled randomized controlled trial will be carried out at the University of Child Health and the Children's Hospital, Lahore consisting of 6 months . In total 60 patients (30 in each group) fulfilling the inclusion criteria will be selected and enrolled in this study. Patients will be divided into two groups; Group A (Injection Etanercept+ Tab methotrexate) and Group B (Injection Etanercept+ Tab methotrexate). Data will be collected at baseline, 1,3 and 6 months. Data will be collected and recorded

Timeline

Start
2026-01-27
Primary completion
2026-07-27
Completion
2026-07-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Etanercept Protein / enzyme biologic 0.8 mg/kg Subcutaneous